BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21834652)

  • 1. RGD-modified endostatin peptide 30 derived from endostatin suppresses invasion and migration of HepG2 cells through the αvβ3 pathway.
    Li S; Wei J; Yuan L; Sun H; Liu Y; Zhang Y; Li J; Liu X
    Cancer Biother Radiopharm; 2011 Oct; 26(5):529-38. PubMed ID: 21834652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
    Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
    Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of HMGB1 on invasion and migration of human hepatoma cell line HepG2 and its mechanism].
    Wang C; Tang C; Chang X; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1159-62. PubMed ID: 24200063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
    Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
    J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.
    Karadag A; Ogbureke KU; Fedarko NS; Fisher LW
    J Natl Cancer Inst; 2004 Jun; 96(12):956-65. PubMed ID: 15199115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells.
    Shih YW; Chien ST; Chen PS; Lee JH; Wu SH; Yin LT
    Cell Biochem Biophys; 2010 Sep; 58(1):31-44. PubMed ID: 20652762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-2 promotes αvβ3 integrin-mediated adhesion and migration of human melanoma cells by cleaving fibronectin.
    Jiao Y; Feng X; Zhan Y; Wang R; Zheng S; Liu W; Zeng X
    PLoS One; 2012; 7(7):e41591. PubMed ID: 22848537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An RGD-modified endostatin-derived synthetic peptide shows antitumor activity in vivo.
    Xu HM; Yin R; Chen L; Siraj S; Huang X; Wang M; Fang H; Wang Y
    Bioconjug Chem; 2008 Oct; 19(10):1980-6. PubMed ID: 18800818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endostar suppresses invasion through downregulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells.
    Lu N; Ling Y; Gao Y; Chen Y; Mu R; Qi Q; Liu W; Zhang H; Gu H; Wang S; Yang Y; Guo Q
    Exp Biol Med (Maywood); 2008 Aug; 233(8):1013-20. PubMed ID: 18480415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9.
    Morgan MR; Thomas GJ; Russell A; Hart IR; Marshall JF
    J Biol Chem; 2004 Jun; 279(25):26533-9. PubMed ID: 15067014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of laver extracts on adhesion, invasion, and migration in SK-Hep1 human hepatoma cancer cells.
    Do Thi N; Hwang ES
    Biosci Biotechnol Biochem; 2014; 78(6):1044-51. PubMed ID: 25036133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
    Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
    Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells.
    Mayoral R; Fernández-Martínez A; Boscá L; Martín-Sanz P
    Carcinogenesis; 2005 Apr; 26(4):753-61. PubMed ID: 15661807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.
    Karadag A; Fedarko NS; Fisher LW
    Cancer Res; 2005 Dec; 65(24):11545-52. PubMed ID: 16357164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of endostatin on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 expression/secretion of bovine choroidal endothelial cells.
    Wang YS; Eichler W; Friedrichs U; Yafai Y; Hoffmann S; Yasukawa T; Hui YN; Wiedemann P
    Curr Eye Res; 2005 Jun; 30(6):479-89. PubMed ID: 16020281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
    Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T
    Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.
    Rolli M; Fransvea E; Pilch J; Saven A; Felding-Habermann B
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9482-7. PubMed ID: 12874388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD-modified endostatin fragments showed an antitumor effect through antiangiogenesis.
    Pu CY; Xu HM; Hu JL; Zheng H; Huang XF; Zhang C; Yang YJ; Li YB
    Anticancer Drugs; 2012 Sep; 23(8):788-802. PubMed ID: 22555196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.